| Page 1880 | Kisaco Research
 

Dr Benjamin Chan

Research Scientist
Yale University

Dr Benjamin Chan

Research Scientist
Yale University

Dr Benjamin Chan

Research Scientist
Yale University
 

Tobi Nagel

Founder & President
Phages for Global Health

Photo Credit: Mark Warren

Tobi Nagel

Founder & President
Phages for Global Health

Tobi Nagel

Founder & President
Phages for Global Health

Photo Credit: Mark Warren

Phages for Global Health is a nonprofit organization that facilitates the application of phages to combat antimicrobial resistance in developing countries. We accomplish this mission in two general ways: by delivering laboratory training workshops through which we teach scientists in developing countries how to isolate and characterize phages locally; and by partnering with developing world researchers to co-develop phage products for specific applications in their countries. Before founding Phages for Global Health, Tobi had 15 years experience in the pharmaceutical industry where she worked with international teams to co-develop products that have been tested in over 80 clinical trials worldwide.

 

Dr Shawna McCallin

Clinical Coordinator
Balgirst University Hospital

Dr Shawna McCallin

Clinical Coordinator
Balgirst University Hospital

Dr Shawna McCallin

Clinical Coordinator
Balgirst University Hospital
 

Scott Stibitz

Microbiologist
Center for Biologics Evaluation and Research, FDA

Scott Stibitz

Microbiologist
Center for Biologics Evaluation and Research, FDA

Scott Stibitz

Microbiologist
Center for Biologics Evaluation and Research, FDA
 

Dr Magda Barbu

Senior Director, Synthetic Biology
C3J therapeutics

Dr. Magda Barbu, Senior Director of Synthetic Biology, leads engineering efforts for C3J’s pipeline of phage therapeutics programs.  Dr. Barbu is an established scientist with over 15 years of experience working with lytic and lysogenic phage in both industry and academia.  Magda combines her deep expertise in molecular biology, phage biology, bacterial pathogenesis and antimicrobial drug development, to set strategy and deliver key preclinical data essential for advancing the synthetic phage programs from bench to clinic. 

 

Dr Magda Barbu

Senior Director, Synthetic Biology
C3J therapeutics

Dr Magda Barbu

Senior Director, Synthetic Biology
C3J therapeutics

Dr. Magda Barbu, Senior Director of Synthetic Biology, leads engineering efforts for C3J’s pipeline of phage therapeutics programs.  Dr. Barbu is an established scientist with over 15 years of experience working with lytic and lysogenic phage in both industry and academia.  Magda combines her deep expertise in molecular biology, phage biology, bacterial pathogenesis and antimicrobial drug development, to set strategy and deliver key preclinical data essential for advancing the synthetic phage programs from bench to clinic. 

 

Dr. Barbu earned her Ph.D. in Microbiology/Molecular Genetics and Biochemistry from the University of Texas Health Science Center at Houston.  Magda completed her postdoctoral training at the MD Anderson Cancer Center, which included identifying druggable targets for cancer and other diseases using in vivo phage display.  She then worked at Synthetic Genomics, Inc. heading up development of the phage engineering platform and related assets, that were subsequently acquired by C3J Therapeutics. Magda has authored 18 peer-reviewed publications, presented worldwide as an invited speaker and received private and priority government grants for her research in antimicrobial therapeutics and synthetic biology.  She has several patents pending.

 

Anna Prokůpková

Policy & Project Officer
European Cancer Leagues

Anna Prokůpková

Policy & Project Officer
European Cancer Leagues

Anna Prokůpková

Policy & Project Officer
European Cancer Leagues
 

Anna Prokůpková

Policy & Project Officer
European Cancer Leagues

Anna Prokůpková

Policy & Project Officer
European Cancer Leagues

Anna Prokůpková

Policy & Project Officer
European Cancer Leagues
 

Fabio Fachin

Head, Cell Therapy Engineering & Automation
Takeda

Fabio Fachin

Head, Cell Therapy Engineering & Automation
Takeda

Fabio Fachin

Head, Cell Therapy Engineering & Automation
Takeda
 

Tatiana Golovina, PhD

Fellow, Cell & Gene Therapy, Process Development
Novartis Pharmaceuticals Corporation

Tatiana Golovina, PhD

Fellow, Cell & Gene Therapy, Process Development
Novartis Pharmaceuticals Corporation

Tatiana Golovina, PhD

Fellow, Cell & Gene Therapy, Process Development
Novartis Pharmaceuticals Corporation